XML 61 R48.htm IDEA: XBRL DOCUMENT
v3.26.1

Significant Transactions - AstralBio License Agreements (Details) - USD ($) | Apr. 21, 2025 | Jan. 28, 2025
--- | --- | ---
Myostatin License Agreement |  |
Significant Transactions |  |
Payment of upfront licensing fee |  | $ 750,000
Number of shares issued |  | 246,087
Aggregate potential milestone payments payable in licensing agreement |  | $ 28,000,000
Equity ownership (ceiling) |  | 19.90%
Activin E License Agreement |  |
Significant Transactions |  |
Payment of upfront licensing fee | $ 750,000 |
Aggregate potential milestone payments payable in licensing agreement | $ 28,000,000 |
Equity ownership (ceiling) | 19.90% |

X
- Definition The ceiling on stock ownership percentage in connection with milestone payments from licensing agreement settled in the form of the Company's common stock + References No definition available. + Details
Name: | ibio_CeilingOnStockOwnershipPercentage
Namespace Prefix: | ibio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential amount of contingent payments payable by the company upon achievement of specified milestones related to the Company's licensing agreement with AstralBio. + References No definition available. + Details
Name: | ibio_PotentialContingentPaymentsRelatedToLicensingAgreement
Namespace Prefix: | ibio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash outflow for fees classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_PaymentsForFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_ExclusiveLicenseAgreementWithAstralbioForMyostatinMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_ExclusiveLicenseAgreementWithAstralbioForActivinEMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |